MinuteClinic Telehealth Now Available in Montana
On April 8, 202, CVS Health announced that MinuteClinic telehealth is now offering Video Visits for patients in the state of Montana. The service is…
Articles by Anastasia Kovalenko
2020 Outbreak of E. coli: FDA’s Report
On April 6, the U.S. Food and Drug Administration published a report on the investigation into the Fall 2020 outbreak of Shiga Toxin-Producing E. coli…
CVS Health Housing Investments in California
CVS Health recently announced, that they have surpassed $200 million in affordable housing investments in California as part of an ongoing commitment to address housing…
FDA Issues EUA for Symbiotica COVID-19 Test Kit
On April 6, the U.S. Food and Drug Administration (FDA) announced it has issued an emergency use authorization (EUA) for the Symbiotica COVID-19 Self-Collected Antibody…
Customers Can Donate Walgreens Cash Rewards
On April 1, Walgreens unveiled a new myWalgreens donation feature, which allows myWalgreens members to donate Walgreens Cash rewards directly to local nonprofits in their…
Walmart COVID-19 Vaccines States Expansion
On April 2, the Walmart Inc. announced about offering Walmart COVID-19 vaccines in 48 states, Puerto Rico and Washington, D.C. “As the COVID-19 vaccine rollout…
Reprocessed Urological Endoscopes Infection Issue
On April 1th, the U.S. Food and Drug Administration (FDA) announced it is investigating numerous medical device reports (MDRs) describing patient infections and other possible…
Walgreens and InComm Payments Announced Their Agreement
On March 30, Walgreens announced an agreement with InComm Payments, a leading global payments technology company, to provide convenient and accessible financial services options for…
FDA Approves Abecma To Treat Multiple Myeloma
The U.S. Food and Drug Administration (FDA) approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not…
Zealand Pharma Announces FDA Approval of Zegalogue (dasiglucagon)
Zealand Pharma announced on March 22, that the U.S. Food and Drug Administration (FDA) has approved Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycemia…